Thomas Ilg

3.5k total citations
65 papers, 2.9k citations indexed

About

Thomas Ilg is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Immunology. According to data from OpenAlex, Thomas Ilg has authored 65 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Public Health, Environmental and Occupational Health, 38 papers in Epidemiology and 19 papers in Immunology. Recurrent topics in Thomas Ilg's work include Research on Leishmaniasis Studies (45 papers), Trypanosoma species research and implications (38 papers) and Toxin Mechanisms and Immunotoxins (11 papers). Thomas Ilg is often cited by papers focused on Research on Leishmaniasis Studies (45 papers), Trypanosoma species research and implications (38 papers) and Toxin Mechanisms and Immunotoxins (11 papers). Thomas Ilg collaborates with scholars based in Germany, Australia and United Kingdom. Thomas Ilg's co-authors include Peter Overath, York‐Dieter Stierhof, Emanuela Handman, Dorothee Harbecke, Michael A. J. Ferguson, Martin Wiese, Paul A. Bates, Sandra Noack, Matthew E. Rogers and M. Gaßel and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Thomas Ilg

65 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Ilg Germany 34 1.9k 1.8k 645 551 444 65 2.9k
Maria Júlia Manso Alves Brazil 35 1.6k 0.8× 2.2k 1.3× 1.4k 2.2× 437 0.8× 375 0.8× 97 3.1k
Santuza Maria Ribeiro Teixeira Brazil 32 1.5k 0.8× 2.2k 1.2× 1.2k 1.9× 297 0.5× 423 1.0× 104 2.9k
Jaime M. Santana Brazil 28 871 0.5× 1.2k 0.7× 796 1.2× 271 0.5× 292 0.7× 92 2.2k
Guy Caljon Belgium 27 1.4k 0.7× 1.5k 0.8× 599 0.9× 416 0.8× 397 0.9× 165 2.6k
Ali Ouaissi France 34 1.8k 0.9× 1.7k 1.0× 668 1.0× 425 0.8× 634 1.4× 92 2.9k
Carlos Robello Uruguay 31 1.2k 0.6× 1.5k 0.8× 1.2k 1.9× 258 0.5× 491 1.1× 129 2.8k
Rodrigo Pedro Soares Brazil 29 1.7k 0.9× 1.3k 0.7× 615 1.0× 370 0.7× 486 1.1× 102 2.6k
Marilyn Parsons United States 39 1.7k 0.9× 2.8k 1.6× 2.6k 4.0× 525 1.0× 837 1.9× 117 4.5k
Claudia M. d’Avila-Levy Brazil 28 1.1k 0.6× 1.2k 0.7× 431 0.7× 154 0.3× 428 1.0× 96 1.9k
Joan Curtis Australia 30 1.7k 0.9× 1.2k 0.7× 399 0.6× 757 1.4× 394 0.9× 51 2.5k

Countries citing papers authored by Thomas Ilg

Since Specialization
Citations

This map shows the geographic impact of Thomas Ilg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ilg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ilg more than expected).

Fields of papers citing papers by Thomas Ilg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Ilg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ilg. The network helps show where Thomas Ilg may publish in the future.

Co-authorship network of co-authors of Thomas Ilg

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Ilg. A scholar is included among the top collaborators of Thomas Ilg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Ilg. Thomas Ilg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Ilg, Thomas, et al.. (2011). The characterization of Lucilia cuprina acetylcholinesterase as a drug target, and the identification of novel inhibitors by high throughput screening. Insect Biochemistry and Molecular Biology. 41(7). 470–483. 12 indexed citations
5.
Werr, Margaret, et al.. (2009). Identification and characterization of two arginine kinases from the parasitic insect Ctenocephalides felis. Insect Biochemistry and Molecular Biology. 39(9). 634–645. 19 indexed citations
6.
Ilg, Thomas, et al.. (2007). Functional characterization of a Drosophila melanogaster succinic semialdehyde dehydrogenase and a non-specific aldehyde dehydrogenase. Insect Biochemistry and Molecular Biology. 38(3). 354–366. 21 indexed citations
7.
Mbuchi, Margaret, Paul A. Bates, Thomas Ilg, John E. Coe, & John G. Raynes. (2006). C-reactive protein initiates transformation of Leishmania donovani and L. mexicana through binding to lipophosphoglycan. Molecular and Biochemical Parasitology. 146(2). 259–264. 1 indexed citations
8.
Stewart, James, Joan Curtis, Timothy P. Spurck, et al.. (2005). Characterisation of a Leishmania mexicana knockout lacking guanosine diphosphate-mannose pyrophosphorylase. International Journal for Parasitology. 35(8). 861–873. 30 indexed citations
10.
Ilg, Thomas, et al.. (2001). Phosphoglycan Repeat-deficient Leishmania mexicana Parasites Remain Infectious to Macrophages and Mice. Journal of Biological Chemistry. 276(7). 4988–4997. 74 indexed citations
11.
Ilg, Thomas. (2000). Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana. The EMBO Journal. 19(9). 1953–1962. 106 indexed citations
12.
Montgomery, Jacqui, Thomas Ilg, Jennifer K. Thompson, Boštjan Kobe, & Emanuela Handman. (2000). Identification and predicted structure of a leucine-rich repeat motif shared by Leishmania major proteophosphoglycan and Parasite Surface Antigen 2. Molecular and Biochemical Parasitology. 107(2). 289–295. 20 indexed citations
13.
Ilg, Thomas, Emanuela Handman, Ken Ng, York‐Dieter Stierhof, & Antony Bacic. (1999). Mucin-Like Proteophosphoglycans from the Protozoan Parasite Leishmania.. Trends in Glycoscience and Glycotechnology. 11(58). 53–71. 17 indexed citations
14.
Stierhof, York‐Dieter, Paul A. Bates, Raymond L. Jacobson, et al.. (1999). Filamentous proteophosphoglycan secreted by Leishmania promastigotes forms gel-like three-dimensional networks that obstruct the digestive tract of infected sandfly vectors. European Journal of Cell Biology. 78(10). 675–689. 74 indexed citations
15.
Ilg, Thomas, et al.. (1999). proteophosphoglycan is expressed by amastigotes and has an immunomodulatory effect on macrophage function. Microbes and Infection. 1(8). 589–599. 50 indexed citations
16.
Stierhof, York‐Dieter, Martin Wiese, Thomas Ilg, et al.. (1998). Structure of a filamentous phosphoglycoprotein polymer: the secreted acid phosphatase of Leishmania mexicana. Journal of Molecular Biology. 282(1). 137–148. 21 indexed citations
17.
Ilg, Thomas, et al.. (1994). Distribution of parasite cysteine proteinases in lesions of mice infected with Leishmania mexicana amastigotes. Molecular and Biochemical Parasitology. 67(2). 193–203. 34 indexed citations
18.
Ilg, Thomas, Dorothee Harbecke, Martin Wiese, & Peter Overath. (1993). Monoclonal antibodies directed against Leishmania secreted acid phosphatase and lipophosphoglycan. European Journal of Biochemistry. 217(2). 603–615. 57 indexed citations
19.
Stierhof, York‐Dieter, et al.. (1993). Expression of lipophosphoglycan, high-molecular weight phosphoglycan and glycoprotein 63 in promastigotes and amastigotes of Leishmania mexicana. Molecular and Biochemical Parasitology. 58(1). 107–121. 109 indexed citations
20.
Komuniecki, Richard, et al.. (1992). Purification of glutathione reductase from muscle of the adult parasitic nematode Ascaris suum. Molecular and Biochemical Parasitology. 51(2). 331–333. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026